In Brief: Clinical Chemistry and Clinical Toxicology Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Clinical Chemistry and Clinical Toxicology Devices Panel: Meeting Dec. 10 at FDA's Corporate Building in Rockville, Maryland to provide the agency with a recommendation on Biex' premarket approval application for its SalEst test, which evaluates samples of salivary estriol to identify women at risk for preterm labor. The PMA includes data from a 956-patient, eight-center blinded study. For more information, contact FDA's Sharon Lappalainen at 301/594-1243, ext. 144...
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.